Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

<i>Shigella</i> is a leading cause of moderate-to-severe diarrhea globally and the causative agent of shigellosis and bacillary dysentery. Associated with 80-165 million cases of diarrhea and over 13% of diarrheal deaths, in many regions <i>Shigella</i> exposure is ubiquitous while infection is heterogenous. To characterize host-genetic susceptibility to <i>Shigella</i>-associated diarrhea, we performed two independent genome-wide association studies (GWAS) including Bangladeshi infants from the PROVIDE and CBC birth cohorts in Dhaka, Bangladesh. Cases were infants with <i>Shigella</i>-associated diarrhea (n=143) and controls were infants with no <i>Shigella</i>-associated diarrhea in the first 13 months of life (n=446). <i>Shigella</i>-associated diarrhea was identified via qPCR Ct distributions for the ipaH gene, carried by all four <i>Shigella</i> species and enteroinvasive <i>Escherichia coli</i> Host GWAS were performed under an additive genetic model. A joint analysis identified protective loci on chromosomes 11 (rs582240, within the <i>KRT18P59</i> pseudogene, P=6.40x10<sup>-8</sup>, OR=0.43) and 8 (rs12550437, within the lincRNA <i>RP11-115J16.1</i>, P=1.49x10<sup>-7</sup>, OR=0.48). Conditional analyses identified two previously suggestive loci, a protective locus on chromosome 7 (rs10266841, within the 3'-UTR of <i>CYTH3</i>, P<sub>conditional</sub>=1.48x10<sup>-7</sup>, OR=0.44) and a risk-associated locus on chromosome 10 (rs2801847, an intronic variant within <i>MPP7</i>, P<sub>conditional</sub>=8.37x10<sup>-8</sup>, OR=5.51). These loci have all been indirectly linked to bacterial Type 3 Secretion System (T3SS) activity, its components, and bacterial effectors delivered into host cells. Host genetic factors that may affect bacterial T3SS activity and are associated with the host response to <i>Shigella</i>-associated diarrhea may provide insight into vaccine and drug development efforts for <i>Shigella</i>-associated diarrheal disease.

Original publication

DOI

10.1128/iai.00012-21

Type

Journal article

Journal

Infection and immunity

Publication Date

03/2021

Addresses

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.